Pregnant women with GDM typically exhibit increased insulin resistance and reduced insulin secretion, which bring about a succession of abnormal metabolisms that are embodied directly by the aberrant expression of corresponding metabolites. The gene discussed is INS; the disease is gestational diabetes.